Company Name: Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. is engaged in the development of medicines for intractable diseases. The company’s pipeline includes multiple RNAi-based product candidates including treatments for chronic hepatitis B virus infection and liver disease associated with alpha-1 antitrypsin deficiency (AATD).
Ticker Symbol: ARWR (NASDAQ)
Company Website: http://arrowheadpharma.com/
Headquarters: Pasadena, CA